ERIKA PASKEY: Open Payments
NPI 1790413730 · ST JOHNS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,506 in 124 payments from 17 companies in 2025. Trend: 2023 $145 · 2024 $1,473 · 2025 $2,506
Food & beverage: $2,506
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 16 | $401 |
| ABBVIE INC. | 19 | $343 |
| Takeda Pharmaceuticals U.S.A., Inc. | 17 | $305 |
| Madrigal Pharmaceuticals | 15 | $273 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 11 | $189 |
| Lilly USA, LLC | 7 | $160 |
| Regeneron Healthcare Solutions, Inc. | 5 | $117 |
| GENZYME CORPORATION | 5 | $116 |
| PFIZER INC. | 5 | $90 |
| Gilead Sciences, Inc. | 3 | $80 |
Products named: TREMFYA, REZDIFFRA, ENTYVIO, DUPIXENT, XIFAXAN, OMVOH, LINZESS, RINVOQ.
Industry payments across FL — which companies pay providers there.
